|Table of Contents|

The clinicopathological features and diagnosis and treatment of the metaplastic carcinoma of the breast

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2018 12
Page:
1958-1961
Research Field:
Publishing date:

Info

Title:
The clinicopathological features and diagnosis and treatment of the metaplastic carcinoma of the breast
Author(s):
Mu FutingLi BinQin YouyouYang Xuewei
Department of Breast Surgery,The Second Affiliated Hospital of Harbin Medical University,Heilongjiang Harbin 150001,China.
Keywords:
metaplastic carcinoma of the breastclinical manifestationpathological featuresdiagnosis and treatment
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2018.12.040
Abstract:
Metaplastic carcinoma of the breast(MBC) is a rare and heterogeneous but aggressive type of breast cancer that has been recognized as a unique pathologic entity by the World Health Organization.MBC might display more benign features and less axillary lymph node metastasis than invasive ductal carcinoma(IDC).Compared with pure IDC,MBC is with specifity because of its unique pathological features.Treatment for MBC is relatively unknown because of the rarity of the disease,but studies suggest that removal of the tumor and adjuvant radiation therapy has the greatest benefit.

References:

[1]Huvos AG,Lucas JC,Foote FW.Metaplastic breast carcinoma.Rare form of mammary cancer[J].New York State Journal of Medicine,1973,73(9):1078-1082.
[2]Benson R,Madan R,Julka PK,et al.Metaplastic carcinoma of breast:A case series of seven patients from a tertiary care center and review of literature[J].Gulf Journal of Oncology,2016,1(3):74-76.
[3]Abd El,Hafez A,Shawky Ael-A.Analysis of metaplastic breat carcinoma:FNAC,histopathology and immunohistochemistry are complementary for diagnosis[J].Breast Diseases,2013,34(2):67-75.
[4]Ashesh Jha,Vivek Agrawal,Nadeem Tanveer,et al.Metaplastic breast carcinoma presenting as benign breast lump[J].Journal of Cancer Research & Therapeutics,2017,13(3):593-596.
[5]A Agarwal.Metaplastic breast carcinoma:A review[J].Indian Journal of Applied Research,2017,7(6):55-56.
[6]DE Boler,H Kara,Y Saglican,et al.Metaplastic carcinoma of the breast:A case series and review of the literature[J].Journal of Oncological Sciences,2016,2:38-42.
[7]H Salhi,O Jaidane,OE Amine,et al.Clinicopathological and therapeutic features of metaplastic carcinoma of the breast:A study of 15 cases[J].International Journal of Reproduction,Contraception,Obstetrics and Gynecology,2017,6(8):3219-3223.
[8]IP Pagnon,BP Mies,MT Martinez,et al.Metaplastic breast carcinoma"fibromatosis like",associated with intraductal papilloma.Case report and literature review[J].Human Pathology:Case Reports,2017,9:15-18.
[9]Toumi Z,Bullen C,Tang AC,et al.Metaplastic breast carcinoma:A case report and systematic review of the literature[J].Pathology International Journal,2011,61(10):582-588.
[10]Choi BB,Shu KS.Metaplastic carcinoma of the breat:Multimodality imaging and histopathologic assessment[J].Acta Radiologica,2012,53(1):5-11.
[11]Abdulwahid M Salih,FH Kakamad,Yadkar A Saeed,et al.Metaplastic breast carcinoma with osseous differentiation:A rare case report[J].International Journal of Surgery Case Reports,2017,34:100-102.
[12]Boram Lee,Sunyoung Lee,Jiwon Sung,et al.Radiotherapy induced secondary cancer risk for breast cancer:3D conformal therapy versus IMRT versus VMAT[J].Journal of Radiological Protection,2014,34(2):325-332.
[13]Emad Rakha.Breast pathology[M].Germany:Springer International Publishing,2017:153-166.
[14]Gahlaut R,Bennett A,Fatayer H,et al.Effect of neoadjuvant chemotherapy on breast cancer phenotype,ER/PR and HER2 expression-Implications for the practising oncologist[J].European Journal of Cancer,2016,60:40-48.
[15]Fabian Leo,Stephan Bartels,Lavinia Magel,et al.Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer[J].Virchows Arch,2016,469:191-201.
[16]S Salimoglu,I Sert,M Emiroglu,et al.Metaplastic breast carcinoma:Analysis of clinical and pathologic characteristics-A case series[J].Journal of Breast Health,2016,12(2):63-66.
[17]A Cimino-Mathews,S Verma,MC Figueroa-Magalhaes,et al.A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma[J].American Journal of Clinical Pathology,2016,145(3):365.
[18]Jagtap SV,Beniwal AA,Shah HP,et al.Metaplastic carcinoma of the breast:A clinicopathological study[J].Evidence Based-Medicine Healthcy,2016,3(34):1666-1669.
[19]Galera P,Khan A,Kandil D.Diagnosis of metaplastic breast carcinoma:Keratin OSCAR versus other cytokeratins[J].Applied Immunohistochemistry & Molecular Morphology Aimm,2016,24(9):622-626.
[20]P Bostrom,A Sainio,N Eigeliene,et al.Human metaplastic breast carcinoma and decorin[J].Cancer Microenvironment,2017(Suppl 2):1-10.
[21]Cimino-Mathews A,Verma S,Figueroa-Magalhaes MC,et al.A clinicopathologic analysis of 45 patients with metaplastic breast carcinoma[J].American Journal of Clinical Pathology,2016,145(3):365-372.
[22]Tzanninis IG,Kotteas EA,Ntanasis-Stathopoulos I,et al.Management and outcomes in metaplastic breast cancer[J].Clinical Breast Cancer,2016,16(6):437-443.
[23]Abd El-Rehim DM,Pinder SE,Paish CE,et al.Expression of luminal and basal cytokeratins in human breast carcinoma[J].Journal of Pathology,2004,661-671.
[24]Rakha EA,El-Rehim DA,Paish C.Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance[J].European Journal of Cancer,2006,42(18):3149-3156.
[25]B Dave,DD Gonzalez.Role of RPL39 in metaplastic breast cancer[J].Journal of the National Cancer Institute,2017,109(6):1093.
[26]Lamya Hamad,Thaer Khourym,Karen Vona,et al.A case of metaplastic breast cancer with prolonged response to single agent liposomal doxorubicin[J].Cureus,2016,8(1):e454.
[27]Kelten C,Boyaci C,Leblebici C,et al.Pregnancy-like hyperplasia and cystic hypersecretory changes adjacent to metaplastic carcinoma of the breast[J].Indian Journal Pathology & Microbiology,2016,59(7):126-127.
[28]Leyrer CM,Berriochoa CA,Agrawal S,et al.Predictive factors on outcomes in metaplastic breast cancer[J].Breast Cancer Research and Treatment,2017,165(3):499-504.
[29]Sylvia Adams.Dramatic response of metaplastic breast cancer to chemoimmunotherapy[J].Npj Breast Cancer,2017,3(1):8.
[30]Choi WJ,Kim HH,Cha JH,et al.Predicting prognostic factors of breast cancer using shear wave elastography[J].Ultrasound in Medicine and Biology,2014,40(2):269-274.
[31]Fayaz S,Demian GA,Eissa HE,et al.Metaplastic breast carcinoma:Analysis of 31 cases from a single institute[J].Journal of the Egyptian National Cancer Institutem,2017,9(3):141-145.
[32]Masahiro Kitada,Shunsuke Yasuda,Nana Takahashi,et al.Clinicopathological study of epithelial metaplastic breast cancer[J].Journal of Cancer Therapy,2016,7:1039-1044.
[33]Archana Ticku,Prem Singh.Metaplastic carcinoma of breast with osteosarcomatous differentiation:A rare case diagnosed by fine needle aspiration cytology[J].Journal of Medical Surgical Pathology,2016,1:103.
[34]U Joneja,S Vranic,J Swensen,et al.Comprehensive profiling of metaplastic breast carcinomas reveals frequent overexpression of programmed death-ligand 1[J].J Clin Pathol,2017,70(3):255.
[35]DE Zein,M Hughes,S Kumar,et al.Metaplastic carcinoma of the breastis more aggressive than triple-negative breast cancer:A study from a single institution and review of literature[J].Clinical Breast Cancer,2017,17(5):382-391.
[36]Iqbal BM,Kumar H,Kambale T,et al.Triple-negative metaplastic breast carcinoma with extensive squamous differentiation in a 55-year-old woman:A rare entity[J].Clinical Cancer Investigation Journal,2017,6:194-196.
[37]M Ghosh,A Muneer,V Trivedi,et al.Metaplastic carcinoma breast:A clinical analysis of nine cases[J].Journal of Clinical and Diagnostic Research,2017,11(8):XR01-XR03.
[38]Slimani O,Saoudi S,Makhlouf T,et al.Metaplastic breast cancer presenting as a breast abscess[J].Archives in Cancer Research,2016,4:4.

Memo

Memo:
-
Last Update: 2018-04-28